Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1739 (LINC01739)

Target
LINC01739
Molecular classification
Long non-coding RNA (lncRNA), Non-protein-coding RNA
01

Overview

Long intergenic non-protein coding RNA 1739 (LINC01739) is an annotated human gene that encodes a long non-coding RNA molecule. LINC01739 does not encode a protein and is not characterized as a classical therapeutic target (receptor, enzyme, etc.). While lncRNAs as a class are increasingly recognized for their regulatory roles in gene expression, chromatin organization, and disease processes, no functional or disease-specific data is currently available for LINC01739. There are no known small molecules, antibodies, or approved drugs that interact with LINC01739, and it is not listed as a clinical biomarker or safety concern. The gene is referenced in genomic databases such as GeneCards, but detailed molecular function, disease association, or therapeutic targeting has not yet been established. Key points: LINC01739 is an lncRNA, not a protein or classical drug target. No direct evidence of involvement in disease, drug interactions, or mechanism of action as a therapeutic target. The canonical name and abbreviation are valid; no misinformation or misspelling is detected. Most lncRNA knowledge comes from broader studies; specific characterization of LINC01739 remains incomplete.

Other names
LINC01739Long intergenic non-protein coding RNA 1739

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1739 (LINC01739).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1739 (LINC01739).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call